structure of Pironetin

Pironetin

CAS No.: 151519-02-7
M. Wt: 324.45500
M. Fa: C19H32O4
InChI Key: XIHGDBYGUWEHCV-FSEPSNHWSA-N

Names and Identifiers of Pironetin

CAS Number

151519-02-7

IUPAC Name

(2R,3R)-3-ethyl-2-[(E,2R,3S,4R,5S)-2-hydroxy-4-methoxy-3,5-dimethylnon-7-enyl]-2,3-dihydropyran-6-one

InChI

InChI=1S/C19H32O4/c1-6-8-9-13(3)19(22-5)14(4)16(20)12-17-15(7-2)10-11-18(21)23-17/h6,8,10-11,13-17,19-20H,7,9,12H2,1-5H3/b8-6+/t13-,14-,15+,16+,17+,19+/m0/s1

InChIKey

XIHGDBYGUWEHCV-FSEPSNHWSA-N

Canonical SMILES

CCC1C=CC(=O)OC1CC(C(C)C(C(C)CC=CC)OC)O

Isomeric SMILES

CC[C@@H]1C=CC(=O)O[C@@H]1C[C@H]([C@H](C)[C@@H]([C@@H](C)C/C=C/C)OC)O

Physical and chemical properties of Pironetin

Acidity coefficient

14.28±0.20(Predicted)

Boiling Point

473.1ºC at 760 mmHg

Density

0.993 g/cm3

Exact Mass

324.23000

Flash Point

160.3ºC

Index of Refraction

1.478

LogP

3.49860

Melting Point

75-77 °C

Molecular Formula

C19H32O4

Molecular Weight

324.45500

PSA

55.76000

Vapour Pressure

6.14E-11mmHg at 25°C

Applications of Pironetin

Pironetin's primary application lies in cancer therapy due to its ability to inhibit microtubule formation. Its unique interaction with tubulin makes it a candidate for developing new anticancer drugs. Additionally, studies suggest potential applications in plant growth regulation and immunosuppression, although these areas require further exploration.

Interaction Studies of Pironetin

Research into pironetin's interactions with tubulin has revealed critical insights into its mechanism of action. The binding of pironetin to α-tubulin not only inhibits polymerization but also alters the structural dynamics between tubulin heterodimers. This perturbation is essential for understanding how pironetin competes with other microtubule-targeting agents like vinblastine and colchicine.

Notable Interactions:
  • Covalent Binding: Cysteine-316 on α-tubulin.
  • Structural Changes: Perturbations in the T7 loop and helix H8 of α-tubulin.

Biological Activity of Pironetin

Pironetin is classified as a microtubule-targeting agent, making it a potent inhibitor of tubulin polymerization. Its ability to disrupt microtubule dynamics is essential for its anticancer properties, as it interferes with cell division and proliferation. In vitro studies have demonstrated that pironetin can induce apoptosis in various cancer cell lines, highlighting its potential as an effective chemotherapeutic agent.

Retrosynthesis analysis of Pironetin

  • Route#1

    Cas:332842-68-9
    Cas:151519-02-7
  • Route#2

    Cas:1576-96-1
    Cas:151519-02-7
  • Route#3

    Cas:59983-36-7
    Cas:151519-02-7